Delivery Order SPE2DB24D2100-SPE2DB25FBGQQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,289.64 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of strong iodine solution in 14ml units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 26, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running...
- This delivery order, valued at $1,223.59 and awarded September 17, 2025, was issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at approximately $1 billion through December 2026. The delivery order was competitively awarded with no set-aside...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,062.16 by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025. This firm fixed price, non-competitive delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,708.00 to AmerisourceBergen Drug Corp on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order, issued under contract number 4569424241, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,060.31 from the Defense Logistics Agency's Medical Supply Chain on August 25, 2025. This firm fixed price delivery order, which is expected to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- This delivery order, issued on September 6, 2025, awards AmerisourceBergen Drug Corp $1,080.31 for pharmaceutical products and medical supplies under a non-set-aside, competitively awarded contract. The award is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The funding originates from the Medical Supply Chain, which operates...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,699.50 by the Defense Logistics Agency's Medical Supply Chain on September 11, 2025. This firm fixed-price delivery order, with a completion date of September 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through...
- This delivery order, awarded September 1, 2025, represents a child contract under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $255,145.60 firm fixed price delivery order is funded through the Medical Supply Chain, a defense agency component, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competitively...
- This delivery order, awarded July 31, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $1,132.80 with a firm fixed price structure, is funded through the Medical Supply Chain division of the Department of Defense. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location, with an ultimate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,441.12 on August 11, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company serves as...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBGQQDelivery Order
This delivery order, valued at $1,653.26, was awarded to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Strong Iodine Solution in 14ml quantities. The order is part of a competitive, non-set-aside procurement funded by the Defense Logistics Agency (DLA), a defense-focused federal agency responsible for supplying medical and pharmaceutical products to the Department of Defense. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a firm fixed-price delivery order, this award is scheduled for ultimate completion by October 16, 2025, reflecting a relatively short fulfillment window consistent with urgent medical supply needs. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen serves the military healthcare system and other government medical programs through this comprehensive global pharmaceutical support vehicle. The parent IDC enables the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas, with individual delivery orders like this one drawn down as specific requirements emerge across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/24/25 |